United States · FDA National Drug Code directory
Olopatadine hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 60505-6222_d84abde6-ee13-fe9c-b477-f7965453aa2d
- Product NDC
- 60505-6222
- Form
- SOLUTION/ DROPS
- Composition / generic term
- Olopatadine hydrochloride
- Labeler
- Apotex Corp.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20221006
- Source listing expiry
- 20261231
Source-listed ingredients
- OLOPATADINE HYDROCHLORIDE — 2 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, PLASTIC in 1 CARTON (60505-6222-2) / 2.5 mL in 1 BOTTLE, PLASTIC (60505-6222-1) · 60505-6222-2
- 2 BOTTLE, PLASTIC in 1 CARTON (60505-6222-3) / 2.5 mL in 1 BOTTLE, PLASTIC · 60505-6222-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →